Arrowhead Pharmaceuticals Inc
ARWR68.160USD
+1.690+2.54%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
9.25BMarket Cap
LossP/E TTM
Arrowhead Pharmaceuticals Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
829.45M
23258.15%
EPS(YoY)
-0.01
99.76%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Arrowhead Pharmaceuticals Inc?
According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 829.45M, with a year-on-year change of 23258.15%.
What is the Earnings Per Share (EPS) of Arrowhead Pharmaceuticals Inc?
According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.012, with a year-on-year change of 99.76%.
What is the net income of Arrowhead Pharmaceuticals Inc?
According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its net income was -1.63M, with a year-on-year change of 99.73%.
What is the net margin of Arrowhead Pharmaceuticals Inc?
According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was 3.63%, with a year-on-year change of 100.02%.
What is the gross margin of Arrowhead Pharmaceuticals Inc?
According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 100.00%, with a year-on-year change of --.
What is the debt-to-asset ratio of Arrowhead Pharmaceuticals Inc?
According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 44.92%, with a year-on-year change of -30.30%.
What is the Return on Equity (ROE) of Arrowhead Pharmaceuticals Inc?
According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -0.50%, with a year-on-year change of 99.81%.
What is the Return on Assets (ROA) of Arrowhead Pharmaceuticals Inc?
According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was 2.39%, with a year-on-year change of 103.73%.
What is the operating profit of Arrowhead Pharmaceuticals Inc?
According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its operating profit was 98.35M, with a year-on-year change of 116.36%.
What are the current assets of Arrowhead Pharmaceuticals Inc?
According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its current assets were 950.64M, with a year-on-year change of 36.69%.
What are the total assets of Arrowhead Pharmaceuticals Inc?
According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its total assets of Arrowhead Pharmaceuticals Inc were 1.39B, with a year-on-year change of 21.54%.
What are the total liabilities of Arrowhead Pharmaceuticals Inc?
According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Arrowhead Pharmaceuticals Inc were 881.88M, with a year-on-year change of -7.05%.
What is the total equity of Arrowhead Pharmaceuticals Inc?
According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its total equity of Arrowhead Pharmaceuticals Inc was 503.42M, with a year-on-year change of 163.48%.
What is the net operating income of Arrowhead Pharmaceuticals Inc?
According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Arrowhead Pharmaceuticals Inc was 30.11M, with a year-on-year change of 104.94%.
What is the net investment of Arrowhead Pharmaceuticals Inc?
According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its net investment of Arrowhead Pharmaceuticals Inc was -129.29M, with a year-on-year change of 69.22%.
What is the net financing of Arrowhead Pharmaceuticals Inc?
According to Arrowhead Pharmaceuticals Inc's FY2025 earnings report, its net financing of Arrowhead Pharmaceuticals Inc was 74.01M, with a year-on-year change of -91.50%.
